neurotranmitter conjugation to glutathione Disulfide - an overview Frontiers | Glutathione S-conjugates as
Description
The phase II clinical trials showed that TLK286 had demonstrated a manageable safety profile as a single agent in patients with ovarian, non-small cell lung, breast, and colorectal cancers (82)
Establishment and application of novel hypoxia-driven dual-reporter model to investigate hypoxic impact on radiation sensitivity in human nasopharyngeal carcinoma xenografts
A large survey indicated that many families and physicians view nutraceuticals as beneficial with minimal adverse effects
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Pesticides applied to crops and amyotrophic lateral sclerosis risk in the U.S
